Pretreatment Thrombocytosis as a Prognostic Factor in Women with Gynecologic Malignancies: a Meta-analysis |
Yu, Min
(Department of Cancer Center, State Key Laboratory of Biotherapy)
Liu, Lei (Department of Cancer Center, State Key Laboratory of Biotherapy) Zhang, Bing-Lan (Department of Cancer Center, State Key Laboratory of Biotherapy) Chen, Qi (Department of Cancer Center, State Key Laboratory of Biotherapy) Ma, Xue-Lei (Department of Cancer Center, State Key Laboratory of Biotherapy) Wu, Yu-Ke (Department of Cancer Center, State Key Laboratory of Biotherapy) Liang, Chun-Shui (Department of Cancer Center, State Key Laboratory of Biotherapy) Niu, Zhi-Min (Department of Cancer Center, State Key Laboratory of Biotherapy) Qin, Xin (Department of Cancer Center, State Key Laboratory of Biotherapy) Niu, Ting (Department of Hematology, West China Hospital, Sichuan University) |
1 | Qiu J, Yu Y, Fu Y, et al (2012). Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer. J Obstet Gynaecol Res, 38, 651-7. DOI ScienceOn |
2 | Riess L (1872). Zur pathologischen anatomie des blutes. Arch Anat Physiol Wissensch Med, 39, 237-49. |
3 | Rodriguez GC, Clarke-Pearson DL, Soper JT, et al (1994). The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstetrics and Gynecology, 83, 445-8. |
4 | Scholz HS, Petru E, Gucer F, et al (2000). Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res, 20, 3983-5. |
5 | Stone RL, Nick AM, McNeish IA, et al (2012). Paraneoplastic Thrombocytosis in ovarian cancer. N Engl J Med, 366, 610-8. DOI ScienceOn |
6 | Tamussino KF, Gucer F, Reich O, et al (2001). Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer, 11, 236-40. DOI ScienceOn |
7 | Taucher S, Salat A, Gnant M, et al (2003). Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost, 89, 1098-106. |
8 | Tomita M, Shimizu T, Hara M, et al (2008). Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. Interact Cardiovasc Thorac Surg, 7, 613-5. DOI ScienceOn |
9 | Altman DG (2001). Systematic reviews of evaluations of prognostic variables. BMJ, 323, 224-8. DOI ScienceOn |
10 | Borsig L (2008). The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther, 8, 1247-55. DOI ScienceOn |
11 | Cho DS, Kim SJ, Lee SH, et al (2011). Prognostic significance of preoperative C-reactive protein elevation andthrombocytosis in patients with non-metastatic renal cell carcinoma. Korean J Urol, 52, 104-9. DOI ScienceOn |
12 | De Jonge ET, Viljoen E, Lindeque BG, et al (1999). The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy. Int J Gynecol Cancer, 9, 198-205. DOI ScienceOn |
13 | Gucer F, Moser F, Tamussino K, et al (1998). Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol, 70, 210-4. DOI ScienceOn |
14 | Gucer F, Tamussino K, Keil F, et al (2004). Thrombocytosis in Gynecologic Malignancies. Ant Res, 24, 2053-60. |
15 | Gorelick C, Andikyan V, Mack M, et al (2009). Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer, 19, 1384-9. DOI ScienceOn |
16 | Grimes DA, Schulz KF (2002). Bias and causal associations in observational research. Lancet, 359, 248-52. DOI ScienceOn |
17 | Gungor T, Kanat-Pektas M, Sucak A, et al (2009). The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet, 279, 53-6. DOI ScienceOn |
18 | Gustavo Rodriguez (1994). Does thrombocytosis have any prognostic significance in cervical cancer? Gynecologic Oncology, 55, 325-7. DOI ScienceOn |
19 | Hayes DF, Isaacs C, Stearns V (2001). Prognostic factors in breast cancer: current and new predictors of metastasis. J Mamm Gland Biol Neo, 6, 375-92. DOI ScienceOn |
20 | Heras P, Hatzopoulos A, Kritikos N, et al (2010). Platelet count and tumor progression in gastric cancer patients. Scand J Gastroenterol, 45, 1005-6. DOI ScienceOn |
21 | Trousseau A, Bazire V, Cormack J, et al (1867). Lectures on clinical medicine, delivered at the Hotel-Dieu. Paris. London: R. Hard-wicke. |
22 | Zeimet AG, Marth C, Muller-Holzner E, et al (1994). Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol, 170, 549-54. DOI ScienceOn |
23 | Zeimet AG, Marth C, Mullner-Holzner E, et al (1993). Clinical relevance of reactive thrombocytosis in patients with ovarian cancer. Gynakol Geburtshilfliche Rundsch, 33, 217-8. |
24 | Hernandez E, Heller PB, Whitney C, et al (1994). Thrombocytosis in surgically treated stage IB squamous Thrombocytosis in surgically treated stage IB squamous cell cervical carcinoma (A Gynecologic Oncology Group study). Gynecol Oncol, 55, 328-32. DOI ScienceOn |
25 | Hernandez E, Lavine M, Dunton CJ, et al (1992). Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer, 69, 2975-7. DOI ScienceOn |
26 | Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB (2000). The significance of thrombocytosis in patients with locally advanced cervical Carcinoma: A Gynecologic Oncology Group Study. Gynecol Oncol, 78, 137-42. DOI ScienceOn |
27 | Li AJ, Madden AC, Cass I, et al (2004). The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol, 92, 211-4. DOI ScienceOn |
28 | Kuyumcuoglu U, Guzel AI, Celik Y, et al (2010). The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor. Eur J Gynarc Oncol, 31, 514-6. |
29 | Lavie O, Comerci G, Daras V, et al (1999). Thrombocytosis in women with vulvar carcinoma. Gynecol Oncol, 72, 82-6. DOI ScienceOn |
30 | Lee M, Kim SW, Nam EJ, et al (2011). The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer. Gynecol Oncol, 122, 238-41. DOI ScienceOn |
31 | Lopes A, Daras V, Cross PA, et al (1994). Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer, 74, 90-2. DOI ScienceOn |
32 | Lukas H, Klaus M, Ben L, et al (2000). Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumor Biol, 21, 309-14. DOI ScienceOn |
33 | Menczer J, Schejter E, Geva D, et al (1998). Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival. Eur J Gynaecol Oncol, 19, 82-4. |
34 | Nash GF, Turner LF, Scully MF, et al (2002). Platelets and cancer. Lancet Oncol, 3, 425-30. DOI ScienceOn |
35 | Nieswandt B, Hafner M, Echtenacher B, et al (1999). Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res, 59, 1295-330. |
36 | Parmar MK, Torri V, Stewart L, et al (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34. DOI ScienceOn |